公开(公告)号：US20240374720A1

公开(公告)日：2024-11-14

申请号：US17928561

申请日：2021-05-28

Applicant: Amgen Inc.

Inventor： Anna IP ,  Ketaki PATEL ,  Clea TALLEY ,  Michael J. TREUHEIT ,  Jun ZHANG

IPC: A61K39/395 ,  A61K47/12 ,  A61K47/18 ,  A61K47/26 ,  C07K16/18

Abstract: Antibody formulations and methods of making and using such formulations are provided herein. The formulation can be for intravenous administration. In some embodiments, the formulation is for subcutaneous administration. In some embodiments, the formulation comprises an anti-C5 antibody, such as eculizumab.